BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12738843)

  • 1. Biomedicine. A view from the top--prion diseases from 10,000 feet.
    Priola SA; Chesebro B; Caughey B
    Science; 2003 May; 300(5621):917-9. PubMed ID: 12738843
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell biology. Prion toxicity: all sail and no anchor.
    Aguzzi A
    Science; 2005 Jun; 308(5727):1420-1. PubMed ID: 15933188
    [No Abstract]   [Full Text] [Related]  

  • 4. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
    Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
    Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spongiform diseases. Waiting for the final experiment.
    Enserink M
    Science; 2005 Dec; 310(5755):1758. PubMed ID: 16357238
    [No Abstract]   [Full Text] [Related]  

  • 6. The state of the prion.
    Weissmann C
    Nat Rev Microbiol; 2004 Nov; 2(11):861-71. PubMed ID: 15494743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Games played by rogue proteins in prion disorders and Alzheimer's disease.
    Aguzzi A; Haass C
    Science; 2003 Oct; 302(5646):814-8. PubMed ID: 14593165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prions: proof of proteinaceous nature but problems with population polymorphisms.
    Griffiths PD
    Rev Med Virol; 2004; 14(6):341-3. PubMed ID: 15495195
    [No Abstract]   [Full Text] [Related]  

  • 9. Structuring the puzzle of prion propagation.
    Eghiaian F
    Curr Opin Struct Biol; 2005 Dec; 15(6):724-30. PubMed ID: 16263262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Unfolding chaperone as a prion protein relating molecule].
    Hachiya NS; Sakasegawa Y; Kaneko K
    Rinsho Shinkeigaku; 2003 Nov; 43(11):817-9. PubMed ID: 15152473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biosynthesis and conversion mechanism of prion protein].
    Ishikawa-Sakurai M; Toda H; Kishida H; Hachiya NS; Kuroiwa Y; Kaneko K
    Uirusu; 2001 Dec; 51(2):159-62. PubMed ID: 11977756
    [No Abstract]   [Full Text] [Related]  

  • 12. Protein-based PCR for prion diseases?
    Telling G
    Nat Med; 2001 Jul; 7(7):778-9. PubMed ID: 11433339
    [No Abstract]   [Full Text] [Related]  

  • 13. Photo-induced crosslinking of prion protein oligomers and prions.
    Piening N; Weber P; Högen T; Beekes M; Kretzschmar H; Giese A
    Amyloid; 2006 Jun; 13(2):67-77. PubMed ID: 16911960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of transgenic mice in the investigation of transmissible spongiform encephalopathies.
    Weissmann C; Fischer M; Raeber A; Büeler H; Sailer A; Shmerling D; Rülicke T; Brandner S; Aguzzi A
    Int J Exp Pathol; 1996 Dec; 77(6):283-93. PubMed ID: 9155663
    [No Abstract]   [Full Text] [Related]  

  • 15. [Molecular pathogenesis of spongiform encephalopathy].
    Aguzzi A; Maddalena A; Brandner S; Klein M
    Pathologica; 1997 Oct; 89(5):481-90. PubMed ID: 9489393
    [No Abstract]   [Full Text] [Related]  

  • 16. Prions and prion diseases.
    Pergami P; Poloni TE; Corato M; Camisa B; Ceroni M
    Funct Neurol; 1999; 14(4):241-52. PubMed ID: 10713898
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intermediate conformer of prion and dynamics based drug design (DBDD)].
    Kazuo K
    Tanpakushitsu Kakusan Koso; 2004 May; 49(7 Suppl):1110-2. PubMed ID: 15168541
    [No Abstract]   [Full Text] [Related]  

  • 18. Why are prion diseases precluded by non-mammals?
    Ji HF; Zhang HY; Chen LL
    Trends Biochem Sci; 2007 May; 32(5):206-8; discussion 208. PubMed ID: 17419063
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
    Sasaki K; Minaki H; Iwaki T
    J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transmembrane form of the prion protein in neurodegenerative disease.
    Hegde RS; Mastrianni JA; Scott MR; DeFea KA; Tremblay P; Torchia M; DeArmond SJ; Prusiner SB; Lingappa VR
    Science; 1998 Feb; 279(5352):827-34. PubMed ID: 9452375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.